Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Holding Co Scilex currently holds 174,770,112 shares of Semnur Pharmaceuticals, Inc. (SMNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Holding Co Scilex has been a net seller of SMNR stock. They have purchased $0 and sold $257.9M worth of shares.
Holding Co Scilex's most recent insider trade was on Jun 15, 2026, when they sold 7,034,737 shares at $0.00 per share.
Holding Co Scilex serves as Executive at Semnur Pharmaceuticals, Inc. (SMNR). They have executed 17 insider transactions totaling $257.9M over their tenure at the company.
Holding Co Scilex holds the position of Executive at Semnur Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Holding Co Scilex has shown a selling trading pattern, with $0 in total purchases and $257.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Holding Co Scilex was on Sep 23, 2025, when they sold $191.1M worth of SMNR shares. This transaction involved 11,945,151 shares at $16.00 per share.
Holding Co Scilex currently owns 174,770,112 shares of Semnur Pharmaceuticals, Inc. (SMNR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Holding Co Scilex's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Holding Co Scilex has 17 Form 4 filings on record as an insider at Semnur Pharmaceuticals, Inc..
Set alerts for Holding Co Scilex and 40,000+ other insiders.